Drug research

iloperidone

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Fanapt

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Randomized Withdrawal Study in Patients With SchizophreniaNCT06961968	Vanda Pharmaceuticals	Phase 3	Recruiting	2027-11Estimated
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled HypertensionNCT07090161	Vanda Pharmaceuticals	Phase 2	Recruiting	2026-10Estimated

Vanda PharmaceuticalsRecruitingPrimary completion: 2027-11 · Estimated

Trial details

Vanda PharmaceuticalsRecruitingPrimary completion: 2026-10 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.